Your session is about to expire
← Back to Search
Mindfulness App for Cancer (MenteCalma Trial)
N/A
Recruiting
Led By David E Victorson, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a Spanish mindfulness app called Wakeful for young adult cancer patients in Colombia. The app guides users through exercises to help them focus and relax over several weeks. Researchers want to see if the app is easy to use and if it helps improve the patients' well-being.
Who is the study for?
This trial is for young adults aged 18-39 who have been diagnosed with cancer and are currently undergoing treatment or have completed it within the last three years. Participants must be fluent in Spanish, able to provide informed consent, and have access to a Wi-Fi-enabled device like a smartphone.
What is being tested?
The study is testing the 'Wakeful' app, which offers mindfulness education in Spanish over nine weeks. It aims to assess how feasible and acceptable this eHealth tool is among Colombian young adult cancer patients as part of an international research partnership.
What are the potential side effects?
Since this intervention involves using a mindfulness app, there are no direct medical side effects expected. However, participants may experience emotional discomfort when engaging with mindfulness practices.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability of the Wakeful program as measured by a post-intervention evaluation survey
Acceptability of the Wakeful program as measured by mindfulness reflections
Adherence to the Wakeful program
+3 moreSecondary study objectives
Change in health behaviors
Change in leisure time physical activity
Change in mindful self-compassion
+3 moreOther study objectives
Meditation experience in young adult cancer survivors
Socio-demographic and clinical factors in mindfulness program participation
Treatment expectancy in young adult cancer survivors
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Wakeful SpanishExperimental Treatment1 Intervention
Wakeful Spanish is the Spanish-language version of Wakeful, developed at Northwestern University. It is a self-directed 9-week digital mindfulness course closely aligned with traditional 8-week Mindfulness-based Stress Reduction (MBSR) programs.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Mindfulness practices, such as those studied in the Wakeful trial, work by promoting a state of focused, nonjudgmental awareness of the present moment. This can help cancer patients manage stress, anxiety, and depression, which are common during cancer treatment.
By reducing psychological distress, mindfulness can improve overall quality of life and potentially enhance the body's ability to cope with cancer. Other common cancer treatments include chemotherapy, which targets rapidly dividing cells; radiation therapy, which damages the DNA of cancer cells; and surgery, which physically removes tumors.
These treatments directly target cancer cells, while mindfulness practices support mental and emotional health, making them a valuable complementary approach.
Randomized Controlled Trial of a 4-Week Mindfulness Intervention among Cancer Survivors Compared to a Breathing Control.Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial.Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study.
Randomized Controlled Trial of a 4-Week Mindfulness Intervention among Cancer Survivors Compared to a Breathing Control.Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial.Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study.
Find a Location
Who is running the clinical trial?
Hospital Universitario San Ignacio Pontificia Universidad JverianaUNKNOWN
Northwestern UniversityLead Sponsor
1,640 Previous Clinical Trials
957,542 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,906 Previous Clinical Trials
41,011,998 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not bedridden and can participate in the study without undue hardship.I have been diagnosed with cancer.I am between 18 and 39 years old.I am currently undergoing or finished my main cancer treatment within the last 3 years.
Research Study Groups:
This trial has the following groups:- Group 1: Wakeful Spanish
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger